Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2023-12-14 09:45:00
Oslo, Norway, December 14, 2023 - EXACT Therapeutics AS ("EXACT-Tx", Euronext
Growth: EXTX), a clinical stage precision health company utilising Acoustic
Cluster Therapy (ACT®) across multiple therapeutic areas, has been invited to
give a presentation at the 14th Annual DNB Nordic Healthcare Conference in Oslo,
Norway.
Per Walday, Chief Executive Officer of EXACT Therapeutics, will present at the
conference today, December 14, 2023, at 16:00 CET.
The presentation will be made available at https://exact-tx.com/finreports
About EXACT-Tx:
EXACT-Tx is a Norwegian clinical-stage precision medicine company developing a
technology platform for targeted therapeutic enhancement - Acoustic Cluster
Therapy (ACT®). ACT® follows a unique approach to ultrasound-mediated, targeted
drug enhancement - with the potential to significantly amplify the clinical
utility of a wide range of therapeutic agents across a multitude of indications
including within oncology (chemotherapy, immunotherapy) and brain diseases.
www.exact-tx.com
For more information, please contact:
Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com